Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

I. Medizinische Klinik und Poliklinik

Klinikum / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10

Zimmermann, A.; Rossmann, H.; Alkhzouz, C. et al.

Dynamic changes of insulin resistance in patients with Gaucher disease type I (GD) under enzyme replacement therapy (ERT)

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES. Bd. 122. H. 3. 2014


Zimmermann, A.; Rossmann, H.; Alkhzouz, C. et al.

Early metabolic alterations and cardiovascular risk in patients with classic congenital adrenal hyperplasia (CAH). Are they reversible by life-style intervention?

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES. Bd. 122. H. 3. 2014


Barreiros, A. P.; Cui, X. W.; Ignee, A. et al.

EchoScopy in Scanning Abdominal Diseases: Initial Clinical Experience

ZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 52. H. 3. 2014 S. 269-275



Maderer, A.; Goepfert, K.; Sauvigny, D. et al.

EL102-a new strategy for targeting hypoxia-driven cancer

ONCOLOGY RESEARCH AND TREATMENT. Bd. 37. 2014 S. 32-32


Schachschal, Guido; Mayr, Michael; Treszl, Andras et al.

Endoscopic versus histological characterisation of polyps during screening colonoscopy

GUT. Bd. 63. H. 3. 2014 S. 458-465


Raggi, Chiara; Factor, Valentina M.; Seo, Daekwan et al.

Epigenetic Reprogramming Modulates Malignant Properties of Human Liver Cancer

HEPATOLOGY. Bd. 59. H. 6. 2014 S. 2251-2262


Thomaidis, Thomas; Weinmann, Arndt; Sprinzl, Martin et al.

Erythropoietin treatment in chemotherapy-induced anemia in previously untreated advanced esophagogastric cancer patients

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY. Bd. 19. H. 2. 2014 S. 288-296


Sivanathan, V.; Kittner, J. M.; Sprinzl, M. F. et al.

Etiology and complications of liver cirrhosis: data from a German centre

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT. Bd. 139. H. 36. 2014 S. 1758-1762


Ganten, T. M.; Stauber, R.; Schott, E. et al.

Final analysis of overall survival per subgroups of HCC patients in the prospective, non-interventional INSIGHT study treated with sorafenib

ONCOLOGY RESEARCH AND TREATMENT. Bd. 37. 2014 S. 123-123